company background image
A003120 logo

Ilsung Pharmaceuticals KOSE:A003120 Stock Report

Last Price

₩22.00k

Market Cap

₩157.8b

7D

-2.0%

1Y

-18.5%

Updated

26 Mar, 2024

Data

Company Financials

Ilsung Pharmaceuticals Co., Ltd.

KOSE:A003120 Stock Report

Market Cap: ₩157.8b

A003120 Stock Overview

Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea.

A003120 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends2/6

Ilsung Pharmaceuticals Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ilsung Pharmaceuticals
Historical stock prices
Current Share Price₩22,000.00
52 Week High₩34,800.00
52 Week Low₩18,710.00
Beta-0.16
1 Month Change-9.28%
3 Month Change-7.37%
1 Year Change-18.52%
3 Year Change33.66%
5 Year Change18.41%
Change since IPO1,347.38%

Recent News & Updates

Recent updates

Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Feb 20
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?

Jan 16
Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?

Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like

Dec 18
Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like

Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Nov 21
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Shareholder Returns

A003120KR PharmaceuticalsKR Market
7D-2.0%5.9%2.1%
1Y-18.5%28.1%13.4%

Return vs Industry: A003120 underperformed the KR Pharmaceuticals industry which returned 28.1% over the past year.

Return vs Market: A003120 underperformed the KR Market which returned 13.4% over the past year.

Price Volatility

Is A003120's price volatile compared to industry and market?
A003120 volatility
A003120 Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement5.2%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A003120 has not had significant price volatility in the past 3 months.

Volatility Over Time: A003120's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1954n/aSeok-geun Yoonhttps://www.ilsung-ph.co.kr

Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular system products. Ilsung Pharmaceuticals Co., Ltd.

Ilsung Pharmaceuticals Co., Ltd. Fundamentals Summary

How do Ilsung Pharmaceuticals's earnings and revenue compare to its market cap?
A003120 fundamental statistics
Market cap₩157.85b
Earnings (TTM)-₩20.94b
Revenue (TTM)₩78.05b

2.0x

P/S Ratio

-7.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A003120 income statement (TTM)
Revenue₩78.05b
Cost of Revenue₩42.02b
Gross Profit₩36.04b
Other Expenses₩56.98b
Earnings-₩20.94b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-3.00k
Gross Margin46.17%
Net Profit Margin-26.83%
Debt/Equity Ratio0%

How did A003120 perform over the long term?

See historical performance and comparison

Dividends

6.8%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.